NATIONAL HEALTH INVESTORS INC
For the period ended Jun 30, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 10, 2026
NHI$71.23-0.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Equity
| Capital in | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total | |||||||
| Shares | Amounts | Par Value | Earnings | Dividends | Interests | Equity | |
| Balances at March 31, 2026 | 48,459,369 | $485 | $1,920,451 | $2,787,108 | $(3,193,269) | $7,837 | $1,522,612 |
| Net income, excluding a net loss of $218 attributable | |||||||
| to redeemable noncontrolling interest | — | — | — | 55,671 | — | (96) | 55,575 |
| Issuance of common shares, net | 642,610 | 6 | 44,928 | — | — | — | 44,934 |
| Equity issuance costs | — | — | (414) | — | — | — | (414) |
| Share-based compensation expense | — | — | 2,360 | — | — | — | 2,360 |
| Grants of restricted stock awards | 3,048 | — | — | — | — | — | — |
| Shares issued due to stock options exercised | 11,710 | — | — | — | — | — | — |
| Taxes paid related to net settlement of stock | |||||||
| incentive awards | (989) | — | (683) | — | — | — | (683) |
| attributable to redeemable noncontrolling interest | — | — | — | — | — | (277) | (277) |
| Dividends declared, $0.92 per share | — | — | — | — | (45,217) | — | (45,217) |
| Balances at June 30, 2026 | 49,115,748 | $491 | $1,966,642 | $2,842,779 | $(3,238,486) | $7,464 | $1,578,890 |
| Capital in | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total | |||||||
| Shares | Amounts | Par Value | Earnings | Dividends | Interests | Equity | |
| Balances at March 31, 2025 | 46,693,671 | $467 | $1,804,679 | $2,638,994 | $(3,017,666) | $8,571 | $1,435,045 |
| Net income, excluding a net loss of $193 attributable | |||||||
| to redeemable noncontrolling interest | — | — | — | 36,987 | — | (105) | 36,882 |
| Issuance of common shares, net | 776,348 | 8 | 57,993 | — | — | — | 58,001 |
| Equity issuance costs | — | — | (106) | — | — | — | (106) |
| Share-based compensation expense | — | — | 1,071 | — | — | — | 1,071 |
| Shares issued due to stock options exercised | 3,794 | — | — | — | — | — | — |
| Taxes paid related to net settlement of stock | |||||||
| incentive awards | (653) | — | (55) | — | — | — | (55) |
| Noncontrolling interest capital contribution | — | — | — | — | — | 56 | 56 |
| attributable to redeemable noncontrolling interest | — | — | — | — | — | (194) | (194) |
| Dividends declared, $0.90 per share | — | — | — | — | (42,727) | — | (42,727) |
| Balances at June 30, 2025 | 47,473,160 | $475 | $1,863,582 | $2,675,981 | $(3,060,393) | $8,328 | $1,487,973 |
| Capital in | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total | |||||||
| Shares | Amounts | Par Value | Earnings | Dividends | Interests | Equity | |
| Balances at December 31, 2025 | 48,302,944 | $483 | $1,922,713 | $2,747,006 | $(3,148,659) | $8,166 | $1,529,709 |
| Net income, excluding a net loss of $474 attributable | |||||||
| to redeemable noncontrolling interest | — | — | — | 95,773 | — | (190) | 95,583 |
| Issuance of common shares, net | 642,610 | 6 | 44,928 | — | — | — | 44,934 |
| Equity issuance costs | — | — | (414) | — | — | — | (414) |
| Share-based compensation expense | — | — | 4,600 | — | — | — | 4,600 |
| Grants of restricted stock awards | 43,045 | — | — | — | — | — | — |
| Shares issued due to stock options exercised | 130,087 | 2 | — | — | — | — | 2 |
| Taxes paid related to net settlement of stock | |||||||
| incentive awards | (2,938) | — | (5,185) | — | — | — | (5,185) |
| attributable to redeemable noncontrolling interest | — | — | — | — | — | (512) | (512) |
| Dividends declared, $1.84 per share | — | — | — | — | (89,827) | — | (89,827) |
| Balances at June 30, 2026 | 49,115,748 | $491 | $1,966,642 | $2,842,779 | $(3,238,486) | $7,464 | $1,578,890 |
| Capital in | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total | |||||||
| Shares | Amounts | Par Value | Earnings | Dividends | Interests | Equity | |
| Balances at December 31, 2024 | 45,687,942 | $457 | $1,736,831 | $2,604,829 | $(2,975,642) | $8,912 | $1,375,387 |
| Net income, excluding a net loss of $436 attributable | |||||||
| to redeemable noncontrolling interest | — | — | — | 71,152 | — | (210) | 70,942 |
| Issuance of common shares, net | 1,736,348 | 18 | 123,466 | — | — | — | 123,484 |
| Equity issuance costs | — | — | (153) | — | — | — | (153) |
| Share-based compensation expense | — | — | 3,629 | — | — | — | 3,629 |
| Grants of restricted stock awards | 29,500 | — | — | — | — | — | — |
| Shares issued due to stock options exercised | 20,557 | — | — | — | — | — | — |
| Taxes paid related to net settlement of stock | |||||||
| incentive awards | (1,187) | — | (191) | — | — | — | (191) |
| Noncontrolling interest capital contributions | — | — | — | — | — | 56 | 56 |
| attributable to redeemable noncontrolling interest | — | — | — | — | — | (430) | (430) |
| Dividends declared, $1.80 per share | — | — | — | — | (84,751) | — | (84,751) |
| Balances at June 30, 2025 | 47,473,160 | $475 | $1,863,582 | $2,675,981 | $(3,060,393) | $8,328 | $1,487,973 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.